Government

WHITE PAPERS AND CASE STUDIES

• Lean Six Sigma Methodology Drives Cost Savings: 2 Success Stories

  Unlock significant lab efficiency and financial gains. See how focused optimization of workflows and asset management led to substantial cost savings and reclaimed six-figure value in consumables.

• 3 Utilities Turning Wastewater Into Opportunity With Advanced Treatment And Reuse

  Read about three of the most pressing wastewater challenges utilities face today and how Stratmoor Hills, Key West Resort Utilities, and Beijing Water Group are using advanced treatment and reuse to overcome them.

• Building A Legacy In Sterile Injectables Through Strong CMO Synergy

  Examine how a CMO can deliver significant value to drug developers by fostering successful outsourcing relationships, streamlining the path to market, and supporting demands.

• Best Practices For Regulatory Excellence In Clinical Research

  Observe how GCLP can integrate ethical and technical standards to ensure reliable, compliant clinical trial data and optimize laboratory operations across sponsors, CROs, and partners.

• Is The Water Sector Ready For AI?

  Despite AI's potential to transform the water sector, fewer than half of organizations are fully ready for adoption. The biggest challenges are procedural and cultural, like fear of change and workforce readiness. Focus on these internal barriers to gain measurable efficiency and sustainability benefits.

• Placing Drug Strategies On A Solid Foundation For Success

  Explore how certain drivers are impacting traditional drug development strategies and relationships with outsourced drug development and manufacturing partners.

• Severn Trent Exceeds Leak Reduction Targets With Innovative Itron Water Solutions

  Severn Trent’s smart metering program, powered by Itron’s technology, is transforming water conservation—reducing leaks by 6 million liters, cutting costs, and empowering customers to use water more wisely.

• FDA Recommendations For Gene Therapy For PMDs

  Explore insight into the strategies and FDA recommendations for executing gene therapy development programs, specifically for primary mitochondrial diseases (PMDs).

• Disclosure Management System: Build Or Buy?

  Clinical trial disclosure regulations are tightening worldwide. In order to maintain compliance, sponsors must determine whether to build an internal disclosure management system or buy a solution.

• How Manufacturers Navigate Labor Shortages, AI, And Quality Challenges

  Review a survey that reveals key industry challenges such as labor shortages, skills gaps, and safety risks, while also spotlighting AI adoption and rising investment in quality innovation.

• Leveraging AI For TMF Classification To Improve Quality, Consistency

  Explore diverse AI methodologies, such as natural language processing and machine learning, elucidating how they seamlessly integrate with current systems to elevate efficiency and uphold quality standards.

• Driving A High-Adherence LTFU Trial Without An EDC

  Discover how our partnership with a client was able to deliver a ten-year long-term follow-up (LTFU) trial that delivered an over 90% adherence rate while keeping trial costs low by not using an EDC.